Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevasizumab vs Triamcinolone in CRVO
NCT01178697Phase 2Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2010
- Primary completion
- Sep 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab MB02 in central retinal vein occlusion (CRVO), sponsored by Shahid Beheshti University of Medical Sciences. Status: unknown.
02
Drugs
bevacizumab MB02
03
Conditions
central retinal vein occlusion (CRVO)
Beyond the preview
Go deeper on NCT01178697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01178697.